Evidence supporting the use of: Cannabidiol
For the health condition: Inflammatory Bowel Disorders

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Cannabidiol (CBD), a non-psychoactive compound found in cannabis, has been studied for its potential role in managing Inflammatory Bowel Disorders (IBD), such as Crohn's disease and ulcerative colitis. Preclinical studies have shown that CBD exhibits anti-inflammatory and immunomodulatory effects in animal models of IBD, reducing colonic inflammation and tissue damage. These effects are hypothesized to be mediated through modulation of the endocannabinoid system, which is involved in gut physiology and immune responses. Additionally, CBD may reduce intestinal motility and visceral pain, which are relevant in IBD symptomatology.

However, current human clinical evidence is limited and mixed. A few small-scale randomized controlled trials and observational studies have shown that CBD may improve some symptoms like abdominal pain and quality of life, but have not consistently demonstrated significant reductions in objective markers of inflammation or disease activity. A 2018 review in Inflammatory Bowel Diseases concluded that while preclinical data is promising, robust clinical evidence is lacking and more large-scale, high-quality trials are needed. The safety profile of CBD appears favorable, but dosing and long-term effects remain unclear.

In summary, the use of cannabidiol for IBD is supported by promising preclinical evidence and some early clinical data, but the overall clinical evidence base is weak, justifying a moderate-low evidence rating.

More about Cannabidiol
More about Inflammatory Bowel Disorders

Other ingredients used for Inflammatory Bowel Disorders

2'-Fucosyllactose
akkermansia muciniphila
algal oil
aloe vera
alpha-glycosyl isoquercitrin
alpha-linolenic acid (ALA)
anthocyanins
bacillus clausii
bacillus subtilis
barberry
barley
beta caryophyllene
bifidobacterium bifidum
bifidobacterium breve
bifidobacterium infantis
bifidobacterium lactis
bifidobacterium longum
butyrate triglyceride
cat's claw
chamomile
citrus pectin
Coptis chinensis
turmeric
curcumin
dandelion
DHA (docosahexaeonic acid)
EPA (eicosapentaenoic acid)
fish oil
flaxseed
fructooligosaccharides (FOS)
inulin
isomalto-oligosaccharide
l-glutamine
lactobacillus brevis
lactobacillus casei
lactobacillus crispatus
lactobacillus fermentum
lactobacillus gasseri
lactobacillus lactis
lactobacillus paracasei
lactiplantibacillus plantarum
lactobacillus reuteri
lactobacillus rhamnosus
lactobacillus salivarius
lactococcus lactis
licorice root
luteolin
marshmallow
n-acetyl-glucosamine
n-acetyl-cysteine (NAC)
nicotinamide riboside
omega-3 fatty acids
pectin
peppermint oil
butyric acid
psyllium
reishi mushroom
saccharomyces boulardii
shiitake mushroom
slippery elm bark
specialized pro-resolving mediators (SPMs)
spirulina
streptococcus thermophilus
tributyrin
Urolithin A
vitamin C
vitamin D
vitamin D3
xylanase
xylooligosaccharides
zinc
bentonite
punarnava
rubia cordifolia
swertia
myrrh
algae
7,14-Hydroxy-Docosapentaenoic Acid
Apigenin
Andrographolide
Avocado
anthocyanidins
Acemannan
Arabinoxylan
Apocynin
Arctiin
Astragalin
Bifidobacterium
Bifidobacterium adolescentis
Brassica
Boswellic Acid
Butternut
Basidiomycota
Boswellia
Bacillus licheniformis
Bioflavonoids
Bifidobacterium animalis
Bacteria
Bifidobacteria
Bacillus
Cichoric acid
Cruciferous
Casticin
Celandine
Chirata
Cannabidiol
Enterococcus
Eicosapentaenoic Acid
Ellagitannin
Fiber

Products containing Cannabidiol

We currently have no products on Vitabase that contain this ingredient.